「with us」の検索結果
13件：1～5件目を表示
-
Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical
Communications with Customers and Provision of Information to Senju Pharmaceutical has a Customer Service Center for directly responding to inquiries from consumers and patients. The role of the Cente...
https://www.senju.co.jp/english/about/csr01.html -
pan as of December 22, 2025. Avarept® Ophthalmic suspension 0.3% represents a novel therapy for DED with Transient Receptor Potential cation channel subfamily V member 1 (TRPV1)*1 antagonist, designed...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222_0.pdf -
研究開発の取り組み | 千寿製薬株式会社
evelopment System R & D Pipeline Clinical trial information Publications Meetings of the Minds Business Collaboration Inquiries licensing★senju.co.jp* When contacting us by e-mail, please change &...
http://www.senju.co.jp/english/rd/ -
pan as of December 22, 2025. Avarept® Ophthalmic suspension 0.3% represents a novel therapy for DED with Transient Receptor Potential cation channel subfamily V member 1 (TRPV1)*1 antagonist, designed...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222.pdf -
Product Development Policy | Research & Development | SENJU Pharmaceutica
Corporate Strategy DivisionProduct Planning DepartmentDirectorYasunobu Maenaka With the management philosophy of “Good Company” and a company that shapes “Beyond eyesight,” we have developed products ...
http://www.senju.co.jp/english/rd/policy/